|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
|
|---|---|---|
| Revenue | ||
| Operating expenses: | ||
| Research and development expenses | ||
| Stock-based compensation | ||
| General and administrative expenses | ||
| Total operating expenses | ||
| Operating loss | ||
| Other expense: | ||
| Interest income | ||
| Other expense, net | ||
| Interest expense | ||
| Other expenses, net | ||
| Total other expenses, net | ||
| Loss before income tax expense | ||
| Income tax benefit | ||
| Loss from continuing operations | ||
| Loss from discontinued operations, net of tax | ||
| Gain on disposal of subsidiaries, net of tax | ||
| Net income from discontinued operations, net of tax | ||
| Net income (loss) for the year | ||
| Other comprehensive income (loss) | ||
| Foreign currency translation (loss) gain, net of taxes | ||
| Total comprehensive income (loss) | ||
| Income (loss) per share: | ||
| continuing operations, basic (in Dollars per share) | ||
| continuing operations, diluted (in Dollars per share) | ||
| discontinued operations, basic (in Dollars per share) | ||
| discontinued operations, diluted (in Dollars per share) | ||
| Total income (loss) per share, basic (in Dollars per share) | ||
| Total income (loss) per share, diluted (in Dollars per share) | ||
| Weighted average number of shares of common stock outstanding: | ||
| Weighted average number of shares of common stock outstanding, basic (in Shares) | ||
| Weighted average number of shares of common stock outstanding, diluted (in Shares) |
Loading...
